Penumbra
PEN
$208.55
Share price
1.21%
Change (1 day)
-30.72%
Change (1 year)
Categories
Penumbra, Inc., is an American company that develops, manufactures and sells medical devices for neurovascular and vascular medicine applications.
Penumbra (PEN) - Total liabilities
Total liabilities on the balance sheet as of December 2023 : $0.37 B
According to Penumbra's latest financial reports the company's total liabilities are $0.37 B. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Penumbra - Total liabilities on balance sheet (from 2014 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023-12-31 | $0.37 B | 1.43% |
| 2022-12-31 | $0.37 B | 28.14% |
| 2021-12-31 | $0.29 B | 56.77% |
| 2020-12-31 | $0.18 B | 2.72% |
| 2019-12-31 | $0.18 B | 94.71% |
| 2018-12-31 | $92.59 M | 21.42% |
| 2017-12-31 | $76.25 M | 82.84% |
| 2016-12-31 | $41.7 M | 33.14% |
| 2015-12-31 | $31.32 M | -76.58% |
| 2014-12-31 | $0.13 B | 68.86% |
| 2013-12-31 | $79.2 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Merit Medical MMSI | $1.12 B | 197.66% | 🇺🇸 USA |
 Inari Medical
NARI | $0.20 B | -44.53% | 🇺🇸 USA |